Open original FDA record ↗Recall record
- FDA identifier
- Z-0811-2018
- Company in FDA record
- NxStage Medical, Inc.
- FDA record creation date
- Mar 1, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
May contain endotoxin levels which have been confirmed to exceed the ANSI/AAMI quality standard dialysis fluid of 0.5 EU/ml when used to prepare product.
Source facts
- Action
- On January 29, 2018 Product Recall Notices & Recall Reply Forms included were emailed to those patients for whom the firm had an email address. Hard copy letters were sent via UPS second day air to patients for whom NxStage did not have an email address. All Dialysis centers were contacted via email. In addition to the active patients and dialysis center consignees of affected product, recall letters were also emailed to the Dialysis Center Home Training Nurse Manager for all active or dropped patients who were shipped affected product, and corporate contacts for national dialysis accounts. Customers are advised to inspect inventory, quarantine, discontinue use and return product. Customers are also encouraged to return the completed Recall Reply Form. Contact NxStage Customer Service to arrange for return of all affected product and for replacement product to be sent. Customers with questions may call Customer Service at 1-866-697-8243.
- Initiated
- 2018-01-29
- Root cause
- Material/Component Contamination
- Terminated
- 2020-04-03
- Distribution
- Worldwide Distribution - USA (nationwide) and to the countries of : United Kingdom & Spain
- Recall number
- Z-0811-2018
- Recall status
- Terminated
- CDRH record ID
- 161554
- FDA record created
- 2018-03-01
- Recall event number
- 79185